Turkey Grappling With Rising Asthma Burden
This article was originally published in PharmAsia News
A new report on asthma in Turkey reveals the real economic cost of the disease for the country. Prepared by four academicians, it highlights the high rate of patients whose disease remains uncontrolled and are not receiving any regular treatment, and notes the role of drug treatment.
You may also be interested in...
Unpaid hospital debts have been hitting the Turkish medical sector for some time, but a government plan to repay less than the full amount owed has angered industry.
Turkey’s efforts to control rising rates of COVID-19 are compromising the ability of hospitals to pay their debts to medtech and pharmaceutical companies. The government has devised a payments plan, but there is catch.
The Turkish medtech industry’s ongoing hospital payments problems appeared likely to come back onto the government’s agenda, with the national economy recovering somewhat in late 2019. But COVID-19 dashed those hopes.